Joana Gostkorzewicz

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The PANCOSTABRAX study evaluated the cost-effectiveness of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine (GEM) versus GEM alone in the treatment of patients(More)
INTRODUCTION GESIDA (AIDS Study Group) has proposed preferred regimens of antiretroviral treatment as initial therapy in HIV infected patients. The objective of this analysis is to compare the costs(More)
  • 1